Enanta Pharmaceuticals Balance Sheet (2012-2026) | ENTA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	57.21M	99.07M	40.99M	28.37M	43.99M	42.22M	73.18M	95.18M	85.39M	39.93M	63.54M	35.77M	37.23M	84.35M	60.21M	44.81M	32.30M	37.44M	34.93M	33.42M
Short-term Investments (Quarter)	186.80M	159.98M	239.34M	224.92M	205.24M	172.25M	136.91M	291.41M		297.22M	236.77M	194.31M	0.61M	132.34M	133.16M		156.57M	148.41M	128.85M	156.09M
Cash & Current Investments (Quarter)	244.00M	259.05M	280.33M	253.29M	249.23M	214.47M	210.08M	386.58M	85.39M	337.15M	300.31M	230.09M	37.84M	216.69M	193.38M	44.81M	188.86M	185.85M	163.77M	189.51M
Receivables - Net (Quarter)	23.58M	27.65M	18.72M	19.48M	20.32M	22.59M	17.80M	18.89M	8.61M	8.17M	7.76M	8.18M	6.65M	7.72M	6.79M	8.33M	6.88M	8.49M	7.81M	6.53M
Receivables - Other (Quarter)
Receivables (Quarter)	23.58M	27.65M	18.72M	19.48M	20.32M	22.59M	17.80M	18.89M	8.61M	8.17M	7.76M	8.18M	6.65M	7.72M	6.79M	8.33M	6.88M	8.49M	7.81M	6.53M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	14.19M	11.51M	14.08M	11.54M	13.45M	17.95M	14.48M	17.07M	13.26M	13.24M	10.93M	15.26M	12.41M	10.68M	8.86M	10.24M	8.59M	4.34M	6.81M	7.58M
Current Assets (Quarter)	319.02M	326.96M	341.87M	313.04M	311.71M	283.70M	271.14M	448.46M	422.79M	390.30M	351.03M	286.58M	299.85M	268.14M	242.86M	222.71M	204.34M	198.68M	178.41M	203.62M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	5.94M	5.43M	4.82M	4.59M	6.17M	8.68M	11.05M	12.01M	11.92M	12.12M	15.48M	25.05M	32.69M	37.37M	37.57M	36.62M	35.40M	34.31M	33.11M	31.94M
Long-Term Investments (Quarter)	108.42M	88.67M	42.22M	39.43M	29.29M	26.94M	15.04M	5.92M				42.51M						56.05M	63.24M	21.99M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.61M	0.09M	0.09M	0.70M	3.97M	0.70M	0.70M	0.83M	3.97M	3.97M	3.97M	3.36M	0.09M	0.09M	3.36M	3.36M	3.36M	0.09M	3.36M	3.36M
Non-Current Assets (Quarter)	119.77M	113.64M	64.95M	72.18M	63.70M	63.83M	55.31M	46.70M	39.48M	38.20M	62.53M	112.24M	76.80M	80.50M	80.13M	78.32M	76.40M	130.82M	136.29M	93.25M
Assets (Quarter)	438.79M	440.59M	406.82M	385.21M	375.41M	347.53M	326.44M	495.17M	462.27M	428.50M	413.56M	398.82M	376.65M	348.64M	322.99M	301.03M	280.73M	329.50M	314.70M	296.87M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	9.54M	7.84M	5.99M	1.25M	6.00M	4.35M	11.76M	7.93M	4.10M	9.33M	6.73M	10.68M	8.00M	4.73M	4.76M	3.55M	1.95M	1.89M	4.36M	3.29M
Payables (Quarter)	9.54M	7.84M	5.99M	1.25M	6.00M	4.35M	11.76M	7.93M	4.10M	9.33M	6.73M	10.68M	8.00M	4.73M	4.76M	3.55M	1.95M	1.89M	4.36M	3.29M
Accumulated Expenses (Quarter)	22.43M	2.42M	21.74M	19.19M	6.44M	2.59M	15.48M	5.03M	18.34M	4.31M	2.97M	4.79M	13.55M	4.09M	2.93M	10.85M	6.47M	7.58M	6.86M	10.18M
Other Accumulated Expenses (Quarter)	6.06M	6.45M	1.12M	1.12M	2.03M	6.86M	0.87M	36.69M	35.08M	2.49M	33.67M	32.30M	34.46M	1.45M	1.57M	27.75M	1.80M	2.05M	1.20M	36.78M
Current Leases (Quarter)	4.20M	3.47M	3.01M	2.60M	2.89M	3.49M	4.92M	5.37M	5.28M	4.97M	3.58M	2.43M	1.52M	1.01M	2.20M	2.39M	3.15M	3.29M	3.76M	3.91M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	36.17M	37.89M	30.74M	23.04M	29.83M	23.00M	32.17M	68.19M	62.79M	62.41M	54.61M	58.23M	57.53M	49.05M	45.95M	44.55M	48.55M	44.73M	46.44M	54.17M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)	1.51M	1.51M	1.51M	1.51M	1.42M	1.42M	1.42M	1.42M	1.42M	1.42M	1.42M	1.42M	1.35M	1.35M	1.35M	1.35M	1.31M	1.31M	1.31M	1.31M
Minority Interest (Quarter)
Operating Leases (Quarter)	1.13M	15.96M	15.12M	22.21M	22.37M	21.86M	23.07M	22.33M	21.24M	20.52M	43.41M	48.14M	53.94M	56.45M	56.54M	55.66M	54.76M	53.78M	52.78M	51.75M
Other Non-Current Liabilities (Quarter)	0.56M	0.86M	0.88M	0.35M		0.41M	0.41M	164.98M	159.43M	0.65M	147.78M	0.23M	0.23M	0.23M	0.24M	119.94M	0.26M	102.82M	0.28M	88.29M
Total Non-Current Liabilities (Quarter)	38.80M	55.35M	47.36M	46.84M	54.08M	46.28M	56.66M	92.37M	86.11M	235.97M	99.67M	249.68M	247.61M	236.59M	229.21M	101.81M	215.75M	100.09M	197.84M	107.51M
Total Liabilities (Quarter)	39.36M	56.21M	48.23M	47.19M	54.08M	46.70M	57.07M	257.35M	245.54M	236.62M	247.44M	249.91M	247.84M	236.83M	229.46M	221.75M	216.01M	202.91M	198.12M	195.80M
Shareholder's Equity
Common Equity (Quarter)	399.43M	384.38M	358.58M	338.02M	321.33M	300.84M	269.38M	237.82M	216.74M	191.88M	166.11M	148.91M	128.81M	111.82M	93.54M	79.28M	64.72M	126.59M	116.59M	101.07M
Liabilities and Shareholders Equity (Quarter)	438.79M	440.59M	406.82M	385.21M	375.41M	347.53M	326.44M	495.17M	462.27M	428.50M	413.56M	398.82M	376.65M	348.64M	322.99M	301.03M	280.73M	329.50M	314.70M	296.87M
Treasury Shares (Quarter)	0.12M	0.14M	0.11M	0.20M	0.10M	0.44M	0.08M	0.42M	0.41M	0.13M	0.44M	0.44M	0.09M	0.44M	0.43M	0.09M	0.41M	0.42M	0.42M	0.42M
Retained Earnings (Quarter)	48.58M	-1.01M	-3.04M	-46.83M	-73.18M	-2.67M	-139.82M	-178.89M	-1.17M	-240.40M	-271.56M	-0.65M	0.30M	-0.03M	-0.22M	-0.40M	-0.34M	-416.87M	-429.96M	-449.46M

Research Tools

Datasets

Plans

Developers

Enanta Pharmaceuticals Balance Sheet (2012-2026) | ENTA

Research Tools

Datasets

Plans

Developers

Enanta Pharmaceuticals Balance Sheet (2012-2026) | ENTA

Create an account

Sign In

Reset Password